Nisa Investment Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-736
| Closed | -$75K | – | 2868 |
|
|
2023
Q2 | $75K | Sell |
736
-5
| -0.7% | -$510 | ﹤0.01% | 1601 |
|
|
2023
Q1 | $67K | Buy |
741
+490
| +195% | +$44.3K | ﹤0.01% | 1626 |
|
|
2022
Q4 | $10K | Buy |
251
+6
| +2% | +$239 | ﹤0.01% | 2215 |
|
|
2022
Q3 | $8K | Sell |
245
-65
| -21% | -$2.12K | ﹤0.01% | 2239 |
|
|
2022
Q2 | $9K | Sell |
310
-17,079
| -98% | -$496K | ﹤0.01% | 2207 |
|
|
2022
Q1 | $570K | Sell |
17,389
-889
| -5% | -$29.1K | ﹤0.01% | 1037 |
|
|
2021
Q4 | $514K | Buy |
18,278
+16,529
| +945% | +$465K | ﹤0.01% | 1005 |
|
|
2021
Q3 | $176 | Sell |
1,749
-739
| -30% | -$74 | ﹤0.01% | 1451 |
|
|
2021
Q2 | $352 | Sell |
2,488
-430
| -15% | -$61 | ﹤0.01% | 1233 |
|
|
2021
Q1 | $291 | Buy |
2,918
+1,200
| +70% | +$120 | ﹤0.01% | 1356 |
|
|
2020
Q4 | $212K | Buy |
1,718
+635
| +59% | +$78.4K | ﹤0.01% | 1445 |
|
|
2020
Q3 | $106K | Sell |
1,083
-1,159
| -52% | -$113K | ﹤0.01% | 1529 |
|
|
2020
Q2 | $350K | Buy |
2,242
+1,219
| +119% | +$190K | ﹤0.01% | 1142 |
|
|
2020
Q1 | $148K | Buy |
1,023
+20
| +2% | +$2.89K | ﹤0.01% | 1269 |
|
|
2019
Q4 | $205K | Sell |
1,003
-427
| -30% | -$87.3K | ﹤0.01% | 1321 |
|
|
2019
Q3 | $115K | Buy |
1,430
+1,280
| +853% | +$103K | ﹤0.01% | 1430 |
|
|
2019
Q2 | $14K | Hold |
150
| – | – | ﹤0.01% | 1674 |
|
|
2019
Q1 | $13K | Buy |
+150
| New | +$13K | ﹤0.01% | 1696 |
|